Literature DB >> 18821877

Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: findings from the ITC Four Country Survey.

David Hammond1, Jessica L Reid, Pete Driezen, K Michael Cummings, Ron Borland, Geoffrey T Fong, Ann McNeill.   

Abstract

AIMS: To measure the prevalence and correlates of nicotine replacement therapy (NRT) use for reasons other than quitting smoking among smokers in four countries. DESIGN AND
SETTING: Population-based, cross-sectional telephone survey with nationally representative samples of adult smokers in Canada, the United States, the United Kingdom and Australia, conducted in 2005. PARTICIPANTS: A total of 6532 adult daily smokers in Canada (n = 1660), the United States (n = 1664), the United Kingdom (n = 1617) and Australia (n = 1591). MEASUREMENTS: Survey questions included demographics, smoking behaviour, use of NRT and reasons for NRT use, as well as access and availability of NRT.
FINDINGS: Approximately 17% of smokers surveyed had used NRT in the past year. Among NRT users, approximately one-third used NRT for a reason other than quitting smoking, including temporary abstinence or reducing the number of cigarettes smoked. The prevalence of non-standard NRT use was remarkably consistent across countries. Using NRT for reasons other than quitting was associated with higher education level, heavier smoking, having no quit intentions, having no past-year quit attempts, the type of NRT product used and accessing NRT without a prescription.
CONCLUSIONS: The use of NRT for purposes other than quitting smoking is fairly common and may help to explain the difficulty in detecting significant quitting benefits associated with NRT use in population studies. Tobacco control policies, including the accessibility of NRT, may have important implications for patterns of NRT use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18821877      PMCID: PMC4605436          DOI: 10.1111/j.1360-0443.2008.02320.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  32 in total

1.  Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status.

Authors:  Anne N Thorndike; Lois Biener; Nancy A Rigotti
Journal:  Am J Public Health       Date:  2002-03       Impact factor: 9.308

2.  Determinants and consequences of smoke-free homes: findings from the International Tobacco Control (ITC) Four Country Survey.

Authors:  R Borland; H-H Yong; K M Cummings; A Hyland; S Anderson; G T Fong
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

3.  Text and graphic warnings on cigarette packages: findings from the international tobacco control four country study.

Authors:  David Hammond; Geoffrey T Fong; Ron Borland; K Michael Cummings; Ann McNeill; Pete Driezen
Journal:  Am J Prev Med       Date:  2007-03       Impact factor: 5.043

4.  Smokers' interest in using nicotine replacement to aid smoking reduction.

Authors:  Saul Shiffman; John R Hughes; Stuart G Ferguson; Janine L Pillitteri; Joseph G Gitchell; Steven L Burton
Journal:  Nicotine Tob Res       Date:  2007-11       Impact factor: 4.244

Review 5.  Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability?

Authors:  Saul Shiffman; Christine T Sweeney
Journal:  Health Policy       Date:  2007-11-01       Impact factor: 2.980

6.  Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study.

Authors:  Anil Batra; Karl Klingler; Björn Landfeldt; Hubertus M Friederich; Ake Westin; Tobias Danielsson
Journal:  Clin Pharmacol Ther       Date:  2005-12       Impact factor: 6.875

7.  A prospective study of off-label use of, abuse of, and dependence on nicotine inhaler.

Authors:  J R Hughes; E H Adams; M A Franzon; M K Maguire; J Guary
Journal:  Tob Control       Date:  2005-02       Impact factor: 7.552

8.  A longitudinal assessment of the impact of smoke-free worksite policies on tobacco use.

Authors:  Joseph E Bauer; Andrew Hyland; Qiang Li; Craig Steger; K Michael Cummings
Journal:  Am J Public Health       Date:  2005-06       Impact factor: 9.308

9.  Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up.

Authors:  Poul Wennike; Tobias Danielsson; Björn Landfeldt; Ake Westin; Philip Tønnesen
Journal:  Addiction       Date:  2003-10       Impact factor: 6.526

10.  Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation.

Authors:  John P Pierce; Elizabeth A Gilpin
Journal:  JAMA       Date:  2002-09-11       Impact factor: 56.272

View more
  20 in total

1.  Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey.

Authors:  James Balmford; Ron Borland; David Hammond; K Michael Cummings
Journal:  Nicotine Tob Res       Date:  2010-12-08       Impact factor: 4.244

Review 2.  Effectiveness of over-the-counter nicotine replacement therapy: a qualitative review of nonrandomized trials.

Authors:  John R Hughes; Erica N Peters; Shelly Naud
Journal:  Nicotine Tob Res       Date:  2011-04-06       Impact factor: 4.244

Review 3.  Does the Magnitude of Reduction in Cigarettes Per Day Predict Smoking Cessation? A Qualitative Review.

Authors:  Elias M Klemperer; John R Hughes
Journal:  Nicotine Tob Res       Date:  2015-03-05       Impact factor: 4.244

Review 4.  Non-cigarette tobacco products: what have we learnt and where are we headed?

Authors:  Richard J O'Connor
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

5.  Use of smoking cessation products: A survey of patients in community pharmacies.

Authors:  Alan Phung; Lauren Luo; Noor Breik; Silvia Alessi-Severini
Journal:  Can Pharm J (Ott)       Date:  2017-08-02

6.  Longitudinal associations between smoking cessation medications and alcohol consumption among smokers in the International Tobacco Control Four Country survey.

Authors:  Sherry A McKee; Kelly C Young-Wolff; Emily L R Harrison; K Michael Cummings; Ron Borland; Christopher W Kahler; Geoffrey T Fong; Andrew Hyland
Journal:  Alcohol Clin Exp Res       Date:  2012-12-14       Impact factor: 3.455

7.  Significance of off-label use of NRT.

Authors:  John R Hughes
Journal:  Addiction       Date:  2008-10       Impact factor: 6.526

8.  Is web interviewing a good alternative to telephone interviewing? Findings from the International Tobacco Control (ITC) Netherlands survey.

Authors:  Gera E Nagelhout; Marc C Willemsen; Mary E Thompson; Geoffrey T Fong; Bas van den Putte; Hein de Vries
Journal:  BMC Public Health       Date:  2010-06-18       Impact factor: 3.295

9.  How do we determine the impact of e-cigarettes on cigarette smoking cessation or reduction? Review and recommendations for answering the research question with scientific rigor.

Authors:  Andrea C Villanti; Shari P Feirman; Raymond S Niaura; Jennifer L Pearson; Allison M Glasser; Lauren K Collins; David B Abrams
Journal:  Addiction       Date:  2017-10-03       Impact factor: 6.526

Review 10.  Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature.

Authors:  Matthew J Carpenter; Bianca F Jardin; Jessica L Burris; Amanda R Mathew; Robert A Schnoll; Nancy A Rigotti; K Michael Cummings
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.